Dose Adjustment and Pharmacodynamic Considerations for Antibiotics in Severe Sepsis and Septic Shock-Reference-Cited by-同舟云学术

Dose Adjustment and Pharmacodynamic Considerations for Antibiotics in Severe Sepsis and Septic Shock

Published:2008 Issue: Volume: Page:97-136
ISSN:
Container-title:Sepsis
language:
Short-container-title:

Author:

Udy Andrew,Roberts Jason,Boots Robert,Lipman Jeffrey

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/978-3-540-79001-3_8.pdf

Reference320 articles.

1. Adembri C, Fallani S, Cassetta MI, et al. (2008) Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion. Int J Antimicrob Agents 31: 122–129.

2. Aeschlimann JR and Rybak MJ (1998) Pharmacodynamic analysis of the activity of quinupristin-dalfopristin against vancomycin-resistant Enterococcus faecium with differing MBCs via time-kill-curve and postantibiotic effect methods. Antimicrob Agents Chemother 42: 2188–2192.

3. Ali MZ and Goetz MB (1997) A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 24: 796–809.

4. Amsden GW (1996) Erythromycin, clarithromycin, and azithromycin: are the differences real? Clin Ther 18: 56–72; discussion 55.

5. Andes D, van Ogtrop ML, and Craig W (1998) Pharmacodynamic activity of a new oxazolidinone linezolid in an animal infection model. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, San Diego, CA.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacodynamic Evaluation: Infectious Diseases;Drug Discovery and Evaluation: Methods in Clinical Pharmacology;2020

2. Pharmacodynamic Evaluation: Infectious Diseases;Drug Discovery and Evaluation: Methods in Clinical Pharmacology;2017-11-27